These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3809183)

  • 1. Prognostic factors in superficial bladder cancer.
    Aso Y; Anderson L; Soloway M; Bouffioux C; Chisholm G; Debruyne F; Kawai T; Kurth KH; Maru A; Straffon WG
    Prog Clin Biol Res; 1986; 221():257-69. PubMed ID: 3809183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic factors in superficial urothelial bladder tumors treated with different therapeutic modalities].
    Rübben H; Lutzeyer W; Morales M; Mittermayer C; Repges R; Zinng E; Zoedler D; Terhorst B; Lymberopoulos S; Steffens L
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():675-83. PubMed ID: 6537132
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consideration of therapeutic choice for grade 3 superficial bladder cancer].
    Noguchi S; Kubota Y; Takase K; Masuda M; Yao M; Hosaka M; Miura T; Kondoh I; Kawasaki C; Moriyama M
    Hinyokika Kiyo; 1996 Sep; 42(9):635-8. PubMed ID: 8918660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural history and prognostic factors of superficial tumors of the bladder].
    Hoznek A; Bellot J; Abbou CC; Chopin DK
    Ann Urol (Paris); 1993; 27(1):20-3. PubMed ID: 8470875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bladder cancer in elderly patients].
    Isaka S; Igarashi T; Akimoto S; Okano T; Shimazaki J; Matsuzaki O
    Hinyokika Kiyo; 1984 Dec; 30(12):1793-9. PubMed ID: 6532207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumors of the bladder in patients under 40 years of age].
    Jemni M; Ben Hassine L; Rabaa F; el Ouakdi M; Ayed M
    J Urol (Paris); 1991; 97(4-5):207-8. PubMed ID: 1761865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of prognostic factors in superficial bladder tumors].
    Páez Borda A; Martín Osés E; de la Cal López M; Llorente Abarca C; Berenguer Sánchez A
    Arch Esp Urol; 1997 Mar; 50(2):121-6. PubMed ID: 9206936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical prognostic factors in superficial cancer of the urinary bladder].
    Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
    Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Superficial bladder cancer. Open questions].
    Böhle A
    Urologe A; 1994 Nov; 33(6):536-9. PubMed ID: 7817453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of squamous cell carcinoma of the bladder].
    Kagawa S; Maebayashi K; Saiki T; Kawano A; Kurokawa K
    Hinyokika Kiyo; 1984 Apr; 30(4):467-9. PubMed ID: 6485958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
    Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
    Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
    Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
    J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining prognostic parameters for urothelial tumors of the bladder.
    Bittard M
    Prog Clin Biol Res; 1984; 162A():161-76. PubMed ID: 6483907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.